{"id":"W2166360124","doi":"10.1056/nejmoa067594","title":"Certolizumab Pegol for the Treatment of Crohn's Disease","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1140,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"National Center for Research Resources; Towson University; University of South Carolina; University of Louisville","keywords":"Certolizumab pegol; Medicine; Placebo; Crohn's disease; Internal medicine; Randomized controlled trial; Gastroenterology; Disease; Adalimumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001938615,0.00009504463,0.0001490405,0.00004120997,0.00003838026,0.000002678807,0.00011897,0.00003330789,0.00003458783],"category_scores_gemma":[0.0002107179,0.00004917674,0.0001196546,0.00002837105,0.0000862937,0.000002206139,0.000006843532,0.0000343106,4.321933e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001744157,"about_ca_system_score_gemma":0.0001600051,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009728787,"about_ca_topic_score_gemma":0.00003285844,"domain_scores_codex":[0.9992933,0.00002476782,0.0003093424,0.00007476705,0.0001643697,0.0001334479],"domain_scores_gemma":[0.9991311,0.00008718423,0.0002084929,0.0001773166,0.0001592495,0.000236699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.08414173,0.0008919555,0.03441496,0.0001908509,0.001186496,0.008245042,0.002193746,0.0002989096,0.06546586,0.000697852,0.03351909,0.7687535],"study_design_scores_gemma":[0.07441541,0.004218046,0.377337,0.0001056613,0.0007405481,0.0006203038,0.0002966537,0.00005813193,0.009017745,0.000508857,0.532505,0.0001766473],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848627,0.004922436,0.006571552,0.002650222,0.0005141576,0.0002465536,0.0000108268,0.000001937902,0.0002196086],"genre_scores_gemma":[0.9942151,0.0007241916,0.000152581,0.000087447,0.004347124,0.000001955573,0.000008925836,0.00001070972,0.0004519751],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7685769,"threshold_uncertainty_score":0.2005369,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01326523126089393,"score_gpt":0.2802427581146855,"score_spread":0.2669775268537916,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}